化合物PGMI-004A T16517
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 1313738-90-7 | ¥2,890.00 | 询底价 |
50 mg | 1313738-90-7 | ¥13,800.00 | 询底价 |
25 mg | 1313738-90-7 | ¥10,600.00 | 询底价 |
100 mg | 1313738-90-7 | ¥17,500.00 | 询底价 |
2 mg | 1313738-90-7 | ¥2,350.00 | 询底价 |
1 mL | 1313738-90-7 | ¥2,960.00 | 询底价 |
Product Introduction
Bioactivity
英文名: PGMI-004A
描述: PGMI-004A 是磷酸甘油酸变位酶 1 抑制剂,IC50=13.1 μM。
体外活性: PGMI-004A inhibits PGAM1 with an IC50 of approximately 13.1 μM and the Kd value of the PGMI-004A-PGAM1 interaction is determined to be 7.2±0.7 μM from the fluorescence-based binding assay. PGMI-004A treatment induces decreased cell proliferation of diverse human cancer and leukemia cells, but not control human dermal fibroblasts (HDF), human foreskin fibroblasts (HFF), human HaCaT keratinocyte cells and human melanocyte PIG1 cells, suggesting minimal non-specific toxicity of PGMI-004A in normal, proliferating human cells. PGMI-004A may allosterically modulate the enzyme activity of PGAM1. The Ki value is determined to be 3.91±2.50 μM using a Dixon plot analysis. The Kd value for protein-ligand interaction is calculated to be 9.4±2.0 μM. PGMI-004A (20 μM) treatment, causes significantly reduced lactate production that is rescued by methyl-2-PG treatment but has no significant effect on intracellular ATP levels. Inhibition of PGAM1 activity by PGMI-004A (20 μM) treatment results in decreased 2-PG and increased 3-PG levels in H1299 cells, which could be rescued by treatment with methyl-2-PG. PGMI-004A (20 μM) treatment results in decreased oxidative PPP flux and NADPH/NADP+ratio, as well as reduced biosynthesis of lipids and RNA, and cell proliferation in H1299 cells [1].
体内活性: PGMI-004A treatment causes significantly decreased tumor growth and tumor size in treated mice compared with mice receiving vehicle control. Treatment with PGMI-004A effectively inhibits PGAM1 enzyme activity in tumors in vivo in resected tumors from xenograft nude mice. The xenograft experiment is performed by injecting H1299 cells to nude mice. Six days post-injection, mice are divided into two groups (n=8/group) and treated with either PGMI-004A (100mg/kg/day) or vehicle for 21 days [1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 125 mg/mL (269.76 mM)
关键字: inhibit | Inhibitor | PGMI 004A | Phosphatase | PGMI-004A | PGMI004A
相关产品: Etidronic acid | Anticancer agent 144 | PTPσ Inhibitor, ISP | (E/Z)-BCI | Rhein-8-glucoside calcium | LMPTP INHIBITOR 1 dihydrochloride | BCI-215 | JAB-3068 | 3α-Aminocholestane | Pentamidine
化合物PGMI-004A T16517信息由TargetMol中国为您提供,如您想了解更多关于化合物PGMI-004A T16517报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途